Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious...
Bristol Myers Squibb Receives Approval for Abecma, the First CAR T Therapy Approved for...
Bristol-Myers Squibb announced that Japan’s Ministry of Health, Labour and Welfare has approved Abecma (idecabtagene...
Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
Evotec SE announced today that the Company has entered into a drug discovery collaboration with...
Ashfield Engage bolsters patient solutions offering in Canada with Medaxis acquisition
Ashfield Engage, part of UDG Healthcare, has announced the acquisition of Medaxis, a patient engagement...
Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene...
Fermenta Biotech Limited announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services...
Genezen appoints Senior Director of Business Development to support rapid growth
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on...
19th Edition of BioAsia to focus on Future Readiness of the Life-Sciences Industry; 2-Day...
19th edition of the Asia’s largest life-sciences and Health Tech forum BioAsia, the annual flagship...
Vetter’s Peter Soelkner featured on the “Molecule to Market” podcast
Peter Soelkner featured on the “Molecule to Market” podcast
Peter Soelkner, one of the managing directors...
Indian Pharmaceutical Industry Now And In The Days To Come
It shouldn’t come as a surprise when we call India a global powerhouse when it...
Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic...
